Shares of Teradyne, Inc. (TER) experienced a significant rally on Friday, closing at $403.20 after a 5.72% gain. The move follows Nasdaq's announcement that the chip-testing company will be added to the Nasdaq-100 index before the market opens on June 22. This inclusion is expected to drive demand from index-tracking funds, providing a substantial boost to the stock.
The stock touched an intraday high of $407.73, bringing Teradyne's market capitalization to approximately $63.6 billion, near its 52-week peak of $422.11. The Nasdaq-100 rebalancing, part of the quarterly review, will also bring in Astera Labs, CoreWeave, Nebius Group, and Rocket Lab, replacing Charter Communications, Cognizant, Insmed, Verisk Analytics, and Zscaler. The index, which tracks the 100 largest non-financial companies on the Nasdaq, is followed by over 200 investment products with assets exceeding $800 billion globally.
Index inclusion typically triggers buying by passive funds, which must adjust their portfolios to reflect the changes. This phenomenon was evident in premarket trading, where Teradyne and the other incoming stocks rose on the news. The additions are expected to increase the index's exposure to the AI infrastructure sector, a theme that has been driving market gains.
Beyond the index-related flows, Teradyne is benefiting from robust demand for AI chip testing. The company reported record first-quarter revenue of $1.282 billion, an 87% year-over-year increase, with GAAP EPS of $2.53 and non-GAAP EPS of $2.56. CEO Greg Smith noted that approximately 70% of revenue is tied to AI-related demand, highlighting the company's strategic position in the AI data center supply chain.
However, the stock's valuation remains a point of contention. Teradyne trades at a trailing price-to-earnings (P/E) ratio of around 75, indicating that investors are paying a premium for current earnings. Analyst price targets suggest the stock may be overvalued: the average 12-month target from 18 analysts on StockAnalysis is $374.82, while MarketBeat's consensus from 16 analysts stands at $339.80, both below Friday's closing price. Despite positive ratings from most analysts, the divergence between price and targets underscores the risk.
The next key catalyst for Teradyne will be the Nasdaq-100 rebalancing on June 22, which could either sustain the rally or lead to a 'sell-the-news' reaction once index funds complete their adjustments. Following that, the company's second-quarter guidance points to revenue between $1.15 billion and $1.25 billion, with non-GAAP EPS of $1.86 to $2.15, both below the record first-quarter results. The next earnings report is scheduled for July 29 after the market close.
Bears argue that the current price already reflects high growth expectations, leaving limited upside. Risks include potential delays from major customers, supply chain disruptions, tariffs, export restrictions, and China's chip regulations. For new buyers, Teradyne represents an expensive bet on AI infrastructure and index fund flows, with a risk-reward profile that appears skewed to the downside.
